---
$id: https://graph.org.ai/products/commodity/51171622
$type: Product
source: UNSPSC
code: "51171622"
title: "Sodium phosphate"
class: "51171600"
classTitle: "Laxatives"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sodium phosphate

**UNSPSC Code**: 51171622
**Class**: [Laxatives](Laxatives.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an electrolyte replacement agent with the molecular formula NAH2PO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SE337SVY37, more generally known as sodium phosphate. European Medicines Agency schedules sodium phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12587MIG. The term SODIUM PHOSPHATE is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 25 , no. 10 1971, list 11. Most nations schedule sodium phosphate under HS 28444030 and SITC 52519. As of Q4 2014, SODIUM PHOSPHATE remains the US FDA Preferred Term for this commodity. Sodium phosphate bears US NLM identifiers UMLS ID C0074757 and NCI Concept Code C29459. SMILES: [O-]P(=O)([O-])[O-].[NA+].[NA+].[NA+].

